These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

746 related items for PubMed ID: 19778164

  • 1. Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination.
    Cady RK, Banks J, Jones BA, Campbell J.
    Curr Med Res Opin; 2009 Nov; 25(11):2711-21. PubMed ID: 19778164
    [Abstract] [Full Text] [Related]

  • 2. Frovatriptan for acute treatment of migraine associated with menstruation: results from an open-label postmarketing surveillance study.
    Newman LC, Harper S, Jones BA, Campbell J.
    J Womens Health (Larchmt); 2009 Aug; 18(8):1265-73. PubMed ID: 19627225
    [Abstract] [Full Text] [Related]

  • 3. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S.
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [Abstract] [Full Text] [Related]

  • 4. Treatment response and tolerability of frovatriptan in patients reporting short- or long-duration migraines at baseline.
    Kelman L, Harper SQ, Hu X, Campbell JC.
    Curr Med Res Opin; 2010 Sep; 26(9):2097-104. PubMed ID: 20642390
    [Abstract] [Full Text] [Related]

  • 5. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
    Silberstein SD, Berner T, Tobin J, Xiang Q, Campbell JC.
    Headache; 2009 Oct; 49(9):1283-97. PubMed ID: 19751371
    [Abstract] [Full Text] [Related]

  • 6. Frovatriptan in the practice of office-based neurologists/pain therapists: Results of postmarketing surveillance study ALADIN.
    Wallasch TM.
    Adv Ther; 2010 Jan; 27(1):56-62. PubMed ID: 20140543
    [Abstract] [Full Text] [Related]

  • 7. Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine.
    Elkind AH, MacGregor EA.
    Expert Rev Neurother; 2008 May; 8(5):723-36. PubMed ID: 18457529
    [Abstract] [Full Text] [Related]

  • 8. Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized study.
    Tullo V, Valguarnera F, Barbanti P, Cortelli P, Sette G, Allais G, d'Onofrio F, Curone M, Zava D, Pezzola D, Benedetto C, Frediani F, Bussone G.
    Cephalalgia; 2014 May; 34(6):434-45. PubMed ID: 24363238
    [Abstract] [Full Text] [Related]

  • 9. The Migraine Intervention Score - a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study.
    Göbel H, Heinze A.
    Int J Clin Pract; 2011 Aug; 65(8):879-86. PubMed ID: 21762313
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic evaluation of frovatriptan.
    Negro A, Lionetto L, Casolla B, Lala N, Simmaco M, Martelletti P.
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1449-58. PubMed ID: 21929465
    [Abstract] [Full Text] [Related]

  • 11. Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine.
    Allais G, Benedetto C.
    Drug Des Devel Ther; 2016 Nov; 10():3225-3236. PubMed ID: 27757013
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The efficacy and tolerability of frovatriptan and dexketoprofen for the treatment of acute migraine attacks.
    Allais G, Rolando S, De Lorenzo C, Benedetto C.
    Expert Rev Neurother; 2014 Aug; 14(8):867-77. PubMed ID: 25056381
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study.
    Spierings EL, Keywood C.
    Pain Med; 2009 Aug; 10(4):633-8. PubMed ID: 19453958
    [Abstract] [Full Text] [Related]

  • 20. Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.
    Guidotti M, Ravasio R.
    Clin Drug Investig; 2009 Aug; 29(11):693-702. PubMed ID: 19813772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.